
Waters Corporation (WAT) Q2 2025 Earnings Call Transcript
Waters Corporation (NYSE:WAT ) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Amol Chaubal - Senior VP & CFO Caspar Tudor - Head of Investor Relations Udit Batra - ...

Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.63 per share a year ago.

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Waters Corporation (NYSE: WAT)
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders a...

Waters and BD Biosciences & Diagnostic Solutions announce $17.5B merger
Waters Corp (NYSE:WAT) shares fell more than 12% after it announced a business combination deal with BD Biosciences & Diagnostic Solutions (NYSE:BDX), forming a new life sciences and diagnostics le...

WAT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Waters Corporation Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Waters Corporation (NYSE: WAT) and BD and Company's Biosciences & Diagnostic Solutio...

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-V...
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market ...

Why Waters (WAT) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Com...
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality...

What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q1 Earnings
Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som...

Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The compa...

Muddy Waters CEO Carson Block on China, Elon Musk, Trump Tariffs and India
Short seller Carson Block, founder and CEO of Muddy Waters, talks about his latest investment strategies and the market's big themes in a fireside chat with Bloomberg Television's Haslinda Amin. 00...

Waters (WAT) Q4 Earnings and Revenues Top Estimates
Waters (WAT) came out with quarterly earnings of $4.10 per share, beating the Zacks Consensus Estimate of $4.02 per share. This compares to earnings of $3.62 per share a year ago.

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in consta...

Weighing In On Waters Corporation: Facing A Valuation Headwind
Today, we take a more in-depth look at Waters Corporation, which provides analytical workflow solutions, primarily to the Pharma and Industrial industries. WAT stock has surged 35% since July lows,...

Muddy Waters Report Triggers Lawsuit Against FTAI Aviation (FTAI) – Hagens Berman
SAN FRANCISCO, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ: FTAI) and certain of its executives, alleging securities fraud.
Related Companies